Chester County News and Community Website
CHESTERBROOK, PA — Persevere Therapeutics appointed oncology executive James Barlow to its board as the Chesterbrook-based biotechnology company prepares to begin a Phase 2a trial of its experimental cancer drug …
Persevere Adds Biotech CEO as Cancer Drug Enters Phase 2 Read More
DREXEL HILL, PA — Delaware County Community College launched a fundraising campaign to equip its new Southeast Center with training technology and career tools, linking private donations to workforce programs …
DCCC Seeks Donor Support for Workforce Training Expansion Read More
PHILADELPHIA, PA — Vivodyne has established a network of 12 automated laboratories capable of testing potential medicines on 3.1 million lab-grown human tissues annually, securing paid early access agreements with …
Vivodyne Scales Human Tissue Testing as Drugmakers Sign On Read More
BERWYN, PA — AscellaHealth released its second-quarter 2026 Specialty & Rare Pipeline Digest, outlining how a growing pipeline of specialty drugs, cell and gene therapies, biosimilars, and treatments for metabolic …
AscellaHealth Releases Midyear Pipeline Outlook as Specialty Costs Rise Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has released draft guidance that could shorten development timelines for gene therapies by allowing drugmakers to make greater use of existing …
FDA Issues Gene Therapy Guidance Aimed at Faster Reviews Read More
WASHINGTON, D.C. — Federal regulators are advancing new safety standards for gene-editing therapies, aiming to speed development of treatments for rare and previously incurable diseases while tightening oversight of potential …
FDA Moves to Fast-Track Gene Editing Safety Standards Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration signaled a sweeping shift in how cutting-edge therapies reach patients this month, unveiling regulatory flexibility for cell and gene therapies, modernizing …
FDA Clears Faster Path for Gene Cures as Rare Disease Breakthrough Arrives Read More
HARRISBURG, PA — Pennsylvania health officials moved to calm growing anxiety over childhood vaccinations on Thursday, reaffirming that there have been no changes to vaccine access, insurance coverage, or school …
Pennsylvania Reaffirms Childhood Vaccine Access as Misinformation Swirls Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) said it has been added to the Nasdaq Biotechnology Index, a move that places the clinical-stage biopharmaceutical company among a select group …
Aclaris Joins Nasdaq Biotech Index, Marking Milestone for Clinical-Stage Firm Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Itvisma, a new adeno-associated virus vector-based gene therapy for spinal muscular atrophy, extending treatment eligibility to adults and children 2 …
FDA Greenlights First Gene Therapy for Older SMA Patients, Raising Hope Nationwide Read More